Ioannis Psallidas

5.5k total citations · 1 hit paper
106 papers, 2.5k citations indexed

About

Ioannis Psallidas is a scholar working on Pulmonary and Respiratory Medicine, Critical Care and Intensive Care Medicine and Surgery. According to data from OpenAlex, Ioannis Psallidas has authored 106 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Pulmonary and Respiratory Medicine, 32 papers in Critical Care and Intensive Care Medicine and 22 papers in Surgery. Recurrent topics in Ioannis Psallidas's work include Pleural and Pulmonary Diseases (68 papers), Ultrasound in Clinical Applications (32 papers) and Lung Cancer Diagnosis and Treatment (28 papers). Ioannis Psallidas is often cited by papers focused on Pleural and Pulmonary Diseases (68 papers), Ultrasound in Clinical Applications (32 papers) and Lung Cancer Diagnosis and Treatment (28 papers). Ioannis Psallidas collaborates with scholars based in United Kingdom, Greece and United States. Ioannis Psallidas's co-authors include Najib M. Rahman, Georgios T. Stathopoulos, Ioannis Kalomenidis, Nick Maskell, Rob Hallifax, José M. Porcel, John Corcoran, Nikolaos I. Kanellakis, Anna Bibby and Rachel Mercer and has published in prestigious journals such as PLoS ONE, JNCI Journal of the National Cancer Institute and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Ioannis Psallidas

99 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A phase 2a trial of the IL-33 monoclonal antibody tozorakimab in patients with COPD: FRONTIER-4

2025 19 citations Dave Singh, Ioannis Psallidas et al. European Respiratory Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ioannis Psallidas United Kingdom	26	1.9k	486	353	343	277	106	2.5k
Seung Ick South Korea	25	976 0.5×	144 0.3×	299 0.8×	374 1.1×	626 2.3×	181	2.2k
William D. Hardie United States	29	1.5k 0.8×	91 0.2×	336 1.0×	235 0.7×	544 2.0×	68	2.3k
Paolo Cameli Italy	27	1.4k 0.8×	94 0.2×	247 0.7×	166 0.5×	281 1.0×	162	2.3k
Matthias Hecker Germany	24	735 0.4×	96 0.2×	363 1.0×	152 0.4×	408 1.5×	102	1.7k
Seung Soo Yoo South Korea	22	640 0.3×	142 0.3×	175 0.5×	356 1.0×	583 2.1×	150	1.7k
M J Hershman United Kingdom	23	516 0.3×	104 0.2×	1.1k 3.2×	775 2.3×	245 0.9×	91	2.2k
Young-Soo Shim South Korea	22	559 0.3×	56 0.1×	362 1.0×	192 0.6×	382 1.4×	54	1.6k
Yilu Zhou China	16	487 0.3×	129 0.3×	128 0.4×	240 0.7×	561 2.0×	41	1.6k
Alessandro Pellegrinelli Italy	16	339 0.2×	85 0.2×	313 0.9×	335 1.0×	209 0.8×	28	1.9k
G. Myllylä Finland	30	346 0.2×	693 1.4×	591 1.7×	142 0.4×	415 1.5×	98	3.0k

Countries citing papers authored by Ioannis Psallidas

Since Specialization

Citations

This map shows the geographic impact of Ioannis Psallidas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ioannis Psallidas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ioannis Psallidas more than expected).

Fields of papers citing papers by Ioannis Psallidas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ioannis Psallidas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ioannis Psallidas. The network helps show where Ioannis Psallidas may publish in the future.

Co-authorship network of co-authors of Ioannis Psallidas

This figure shows the co-authorship network connecting the top 25 collaborators of Ioannis Psallidas. A scholar is included among the top collaborators of Ioannis Psallidas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ioannis Psallidas. Ioannis Psallidas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fagerås, Malin, et al.. (2025). Current Smoking and Pharmacological Treatment Responses in Chronic Obstructive Pulmonary Disease: Not Clear-Cut. American Journal of Respiratory and Critical Care Medicine. 211(11). 2223–2224. 1 indexed citations

Saraiva, Gabriela Luporini, Juan Li, Donald E. Brooks, et al.. (2025). Safety Profile of Tozorakimab (an Anti-IL-33 Monoclonal Antibody): Data from the FRONTIER Phase 2 Program of 1076 Patients. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A1373–A1373. 1 indexed citations

Singh, Dave, Gerard J. Criner, Àlvar Agustí, et al.. (2023). Benralizumab Prevents Recurrent Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis. International Journal of COPD. Volume 18. 1595–1599. 17 indexed citations

Weidolf, Lars, Sofia Necander, Elwin Verheij, et al.. (2022). Characterization of Clinical Absorption, Distribution, Metabolism, and Excretion and Pharmacokinetics of Velsecorat Using an Intravenous Microtracer Combined with an Inhaled Dose in Healthy Subjects. Drug Metabolism and Disposition. 50(2). 150–157. 4 indexed citations

Psallidas, Ioannis, Vibeke Backer, Piotr Kuna, et al.. (2020). A Phase 2a, Double-Blind, Placebo-controlled Randomized Trial of Inhaled TLR9 Agonist AZD1419 in Asthma. American Journal of Respiratory and Critical Care Medicine. 203(3). 296–306. 17 indexed citations

Kanellakis, Nikolaos I., John Wrightson, Rob Hallifax, et al.. (2019). Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients. BMJ Open Respiratory Research. 6(1). e000440–e000440. 5 indexed citations

Luengo-Fernández, Ramón, Erika Penz, Melissa Dobson, et al.. (2019). Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection: evidence from the MIST2 randomised controlled trial. European Respiratory Journal. 54(2). 1801550–1801550. 13 indexed citations

Hassan, Maged, Rachel Mercer, Nick Maskell, et al.. (2019). Survival in patients with malignant pleural effusion undergoing talc pleurodesis. Lung Cancer. 137. 14–18. 25 indexed citations

Lamort, Anne‐Sophie, Ioanna Giopanou, Ioannis Psallidas, & Georgios T. Stathopoulos. (2019). Osteopontin as a Link between Inflammation and Cancer: The Thorax in the Spotlight. Cells. 8(8). 815–815. 122 indexed citations

10.

Bibby, Anna, Patrick Dorn, Ioannis Psallidas, et al.. (2018). ERS/EACTS statement on the management of malignant pleural effusions. European Respiratory Journal. 52(1). 1800349–1800349. 171 indexed citations

11.

Psallidas, Ioannis, Nikolaos I. Kanellakis, Stephen Gerry, et al.. (2018). Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis. The Lancet Oncology. 19(7). 930–939. 82 indexed citations

12.

Glatzer, Markus, Achim Rittmeyer, Joachim Müller, et al.. (2017). Treatment of limited disease small cell lung cancer: the multidisciplinary team. European Respiratory Journal. 50(2). 1700422–1700422. 16 indexed citations

13.

Corcoran, John, Emma Culver, Tamsin Cargill, et al.. (2017). Thoracic involvement in IgG4-related disease in a UK-based patient cohort. Respiratory Medicine. 132. 117–121. 22 indexed citations

14.

Talwar, Arunabh, et al.. (2016). P4 A prospective assessment of the clinical utility of intercostal artery identification in pleural intervention. Thorax. 71(Suppl 3). A84.2–A85. 1 indexed citations

15.

Magkouta, Sophia, et al.. (2015). Temsirolimus targets multiple hallmarks of cancer to impede mesothelioma growth in vivo. Respirology. 20(8). 1263–1271. 14 indexed citations

16.

Corcoran, John, et al.. (2015). Ultrasound-guided pneumothorax induction prior to local anaesthetic thoracoscopy: Table 1. Thorax. 70(9). 906–908. 26 indexed citations

17.

Karabela, Sophia P., Ioannis Psallidas, Taylor P. Sherrill, et al.. (2012). Opposing effects of bortezomib-induced nuclear factor- B inhibition on chemical lung carcinogenesis. Carcinogenesis. 33(4). 859–867. 13 indexed citations

18.

Zarogiannis, Sotirios G., Ioannis Psallidas, Chrissi Hatzoglou, Konstantinos I. Gourgoulianis, & Ioannis Kalomenidis. (2010). Dexamethasone acutely accelerates pleural fluid absorption in mice hydrothoraces. The Journal of Physiological Sciences. 60(4). 299–302. 8 indexed citations

19.

Stathopoulos, Georgios T., Charalampos Moschos, Heleni Loutrari, et al.. (2008). Zoledronic Acid Is Effective against Experimental Malignant Pleural Effusion. American Journal of Respiratory and Critical Care Medicine. 178(1). 50–59. 39 indexed citations

20.

Stathopoulos, Georgios T., Androniki Kollintza, Charalampos Moschos, et al.. (2007). Tumor Necrosis Factor-α Promotes Malignant Pleural Effusion. Cancer Research. 67(20). 9825–9834. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact